Skip to main content
Celon Pharma S.A. logo

Celon Pharma S.A. — Investor Relations & Filings

Ticker · CLN ISIN · PLCLNPH00015 LEI · 259400Q0ERJT0NC5DT24 WAR Manufacturing
Open in API
Filings indexed 709 across all filing types
Latest filing 2018-04-16 Annual Report
Country PL Poland
Listing WAR CLN

About Celon Pharma S.A.

https://celonpharma.com/en/

Celon Pharma S.A. is an integrated pharmaceutical company that conducts advanced research and manufactures modern drugs. The company is engaged in the development, production, distribution, and marketing of therapeutic solutions. Its primary focus is on developing treatments for cancers, neurological diseases, diabetes, and other metabolic disorders. As a marketing authorization holder, Celon Pharma manages the full product lifecycle, from scientific research and development to commercialization, aiming to improve patient health and quality of life.

Recent filings

Filing Released Lang Actions
Raport Roczny 2017
Annual Report Classification · 100% confidence The document is a comprehensive annual report for Celon Pharma S.A. for the fiscal year 2017. It includes a letter from the CEO, a detailed table of contents covering financial statements, management reports (Sprawozdanie Zarządu z działalności), corporate governance, and remuneration policies, as well as the beginning of the financial statements section. Given the depth and scope of the content, it is clearly an Annual Report (10-K equivalent). FY 2017
2018-04-16 Polish
Pismo Prezesa Zarządu
Management Reports Classification · 95% confidence The document is a letter from the CEO of Celon Pharma S.A. addressing shareholders regarding the company's activities, strategic direction, and business outlook for the year 2017. It functions as a management commentary or a letter to shareholders typically found at the beginning of an annual report. Since it does not contain the full financial statements or the formal audit report, but rather serves as a narrative overview of the company's performance and future strategy, it is best classified as a Management Report (MDA). FY 2017
2018-04-16 Polish
Oświadczenie Zarządu w sprawie firmy audytorskiej
Board/Management Information Classification · 97% confidence The document is titled "Oświadczenie Zarządu" (Management Statement/Declaration) in Polish. The content explicitly states that the management board declares that the entity authorized to audit the financial statements has been selected in accordance with the law, and that the auditors meet the requirements for expressing an impartial and independent opinion. This type of formal declaration regarding the audit process and auditor independence is a key component often found within or accompanying formal financial reports, but it is not the full financial report itself (like 10-K or IR). It relates directly to the audit process and compliance. Given the options, it most closely aligns with the scope of an Audit Report/Information (AR), as it is a formal statement concerning the audit, or potentially Governance Information (CGR). However, since it specifically addresses the auditor's qualifications and the audit process compliance, AR is the most precise fit among the provided definitions, as it covers 'applied accounting principles, and results of internal or regulatory stress tests (excluding full Annual Reports)'. The document is short and formal, suggesting a required compliance statement related to the audit.
2018-04-16 Polish
Oświadczenie Zarządu w Sprawie Rzetelności Sporządzenia Sprawozdania Finansowego
Management Reports Classification · 95% confidence The document is titled "Oświadczenie Zarządu" (Management Statement/Declaration) and contains affirmations from the Management Board (Zarząd) regarding the accuracy and fairness of the annual financial statements and the management report, according to Polish accounting principles. This type of formal declaration, often required to accompany annual financial filings, aligns best with the concept of Management's Discussion and Analysis or a formal management statement accompanying the annual report, but since it is a specific declaration about the financial statements' fairness rather than a full analysis, it fits the 'Management Reports' (MDA) category, which covers management explanations of results and outlook, or potentially an Audit Report/Information (AR) if it were a formal sign-off on the audit, but the content is clearly a management assertion. Given the options, MDA (Management Reports) is the most appropriate fit for a formal management declaration accompanying financial results.
2018-04-16 Polish
Sprawozdanie z badania rocznego sprawozdania finansowego
Audit Report / Information Classification · 99% confidence The document is titled "Sprawozdanie niezależnego biegłego rewidenta z badania" (Independent Auditor's Report on the Audit) and explicitly states it is an opinion on the "roczne sprawozdanie finansowe" (annual financial statement) for the year ended December 31, 2017. It details the auditor's opinion, the basis for the opinion, the scope of the audit, and discusses Key Audit Matters (KAMs) like capitalization of development costs and accounting for grants. This content is characteristic of an Audit Report, which, when standalone or accompanying the annual report, falls under the 'Audit Report / Information' category, distinct from the full 'Annual Report (10-K)' which is a specific SEC filing type not applicable here, or the 'Interim Report (IR)'. Given the Polish context and the specific nature of the auditor's opinion on the annual accounts, the most appropriate classification is AR (Audit Report / Information). FY 2017
2018-04-16 Polish
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na Nadzwyczajnym Walnym Zgromadzeniu Spółki w dniu 9 kwietnia 2018 r. - Content (PL)
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document text is very short (742 characters) and explicitly details the voting results and the percentage of votes held by major shareholders (Glatton sp. z o.o. and Generali Otwarty Fundusz Emerytalny) during an Extraordinary General Meeting (Nadzwyczajnym Walnym Zgromadzeniu) held on April 9, 2018. This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes at any general meeting.
2018-04-16 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.